Best Practices for Managing Side Effects of Cancer Treatment
OSCEs for Intensive Care Medicine is a comprehensive revision resource for doctors preparing to take the Fellowship of the Faculty of Intensive Care Medicine (FFICM) and the European Diploma in Intensive Care Medicine (EDIC). Written by a team of ...
Get a quick, expert overview of the latest clinical information and guidelines for cancer checkpoint inhibitors and their implications for specific types of cancers. This practical title by Drs. Fumito Ito and Marc Ernstoff synthesizes the most up...
Foreword Introduction Part 1: Immune Checkpoint Inhibitors in the Clinic Chapter One: Overview of Anti-CTLA-4 Agents: Ipilimumab and Tremilimumab Daniel Hartman Johnson and Jianjun Gao Chapter Two: Overview of PD-1 and PD-L1 Inhibitors Nikolaos Andreatos, Shailender Bhatia, and Petros Grivas Chapter Three: Indications and Toxicities of Immune Checkpoint Inhibitor Combinations Lavinia Spain, Michael A. Postow, James Larkin, and Jeffrey Weber Part 2: Specific Immune Checkpoint Inhibitor Toxicities Chapter Four: General Principles of Immune-Related Toxicities Osama E. Rahma and Patrick A. Ott Chapter Five: Dermatological Toxicities: Rash, Mucosal Irritation, and Pruritus Jennifer Wu and Mario E. Lacouture Chapter Six: Musculoskeletal and Rheumatologic Toxicities Noha Abdel-Wahab, Clifton O. Bingham III, and Maria Suarez-Almazor Chapter Seven: Immune-Related Gastrointestinal Toxicities Hamzah Abu-Sbeih, Daniel Johnson, Yinghong Wang Chapter Eight: Pneumotoxicity Associated with Immune Checkpoint Blockades Vickie R. Shannon Chapter Nine: Immune-Related Endocrinopathies Associated with Immune Checkpoint Inhibitors Rajeev Sharma, Ha Nguyen, Ramona Dadu Chapter Ten: Neurologic Adverse Events and Neurologic Complications Haroon Ahmad, Jasmin Jo, Elizabeth Gaughan, Camilo Fadul Chapter Eleven: Cardiovascular Toxicities Related to Immune Checkpoint Inhibitors Pankit Vachhani, Igor Puzanov, Javid J. Moslehi Chapter Twelve: Renal Toxicities Associated with Immune Checkpoint Inhibitors Ala Abudayyeh, Maen Abdelrahim, Laurence Albiges Chapter Thirteen: Hematologic Toxicities of Apparent Immune-Related Origins George L. Chen, Caroline Robert, Alexander M. Lesokhin Chapter Fourteen: Ocular Toxicities Caused by Immune Dysregulation Liliya Golas and Dimitra Skondra Chapter Fifteen: Safety and Regulation of Immune Checkpoint Inhibitors in Special Patient Populations Douglas B. Johnson, Ryan Sullivan, Paolo A. Ascierto Chapter Sixteen: Cancer-Related Fatigue in Patients of Immune Checkpoint Inhibitor Therapy Eric D. Hansen, Michelle Walter, Amy A. Case Chapter Seventeen: Cost Effectiveness and Financial Toxicity in New Cancer Therapies Christine Kohn, Natalia Shcherbakova, Alberto J. Montero